Search International and National Patent Collections

1. (WO2018088877) ANTIBODY BINDING SPECIFICALLY TO CD66C AND USE THEREOF

Pub. No.:    WO/2018/088877    International Application No.:    PCT/KR2017/012891
Publication Date: Fri May 18 01:59:59 CEST 2018 International Filing Date: Wed Nov 15 00:59:59 CET 2017
IPC: C07K 16/28
A61K 39/395
G01N 33/574
Applicants: DINONA
다이노나(주)
Inventors: YOON, Sangsoon
윤상순
HONG, Kwon Pyo
홍권표
KIM, Soseul
김솟을
JI, Gil Yong
지길용
LIM, Young Hoon
임영훈
Title: ANTIBODY BINDING SPECIFICALLY TO CD66C AND USE THEREOF
Abstract:
The present invention relates to an anti-CD66c antibody and a use thereof for cancer treatment and, particularly, to an antibody that can induce T-cell activation or the humoral immune response by using the antibody specifically recognizing CD66c, and recognize and bind to CD66c; a nucleic acid molecule encoding the antibody or an antigen-binding fragment; a vector and a host cell comprising the nucleic acid molecule; and a use of the antibody or the antigen-binding fragment for alleviation, prevention, treatment, or diagnosis of CD66c related diseases, for example, solid cancer.